Focus: Nebula Genomics is a consumer genomics company specializing in affordable whole-genome sequencing and blockchain-enabled personal data monetization, headquartered in San Francisco.
Profile data last refreshed 46m ago · AI intelligence enriched 1w ago
Growing — net +5 jobs in 30d
5 jobs added vs 0 removed. Steady team buildout.
Best suited for early-career professionals interested in consumer health tech, data science, or business innovation rather than traditional drug development or large-organization stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Nebula Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Nebula Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub